dihydroquercetin pentacaprylate은 임신 중 안전한가요?
No harmonised CLP reproductive classification or SCCS/CIR safety assessment was found for dihydroquercetin pentacaprylate. Peer‑reviewed animal and in vitro studies on the parent compound (taxifolin/dihydroquercetin) report no evidence of intrinsic reproductive/teratogenic hazard and in some cases show protective effects against chemical‑induced reproductive damage, so there is no credible evidence to up‑rank hazard. (See CosIng listing for the INCI and PubMed studies on taxifolin.) Sources: EU Official Journal (Cosmetic ingredient listing), PubMed studies on taxifolin reproductive effects.
Related ingredients
Frequently asked questions
- dihydroquercetin pentacaprylate은 임신 중 안전한가요?
- No harmonised CLP reproductive classification or SCCS/CIR safety assessment was found for dihydroquercetin pentacaprylate. Peer‑reviewed animal and in vitro studies on the parent compound (taxifolin/dihydroquercetin) report no evidence of intrinsic reproductive/teratogenic hazard and in some cases show protective effects against chemical‑induced reproductive damage, so there is no credible evidence to up‑rank hazard. (See CosIng listing for the INCI and PubMed studies on taxifolin.) Sources: EU Official Journal (Cosmetic ingredient listing), PubMed studies on taxifolin reproductive effects.
- dihydroquercetin pentacaprylate은 모유 수유 중 안전한가요?
- No data specific to lactation or breastmilk transfer for the pentacaprylate or parent dihydroquercetin were located. Because there is no evidence of reproductive toxicity or endocrine disruption for the parent and no harmonised flags, hazard and mechanism remain 0. Exposure from topical cosmetic use was not shown to be high. No SCCS/CIR contraindication found.
- dihydroquercetin pentacaprylate은 아기 피부에 안전한가요?
- Hazard/mechanism: no infant‑specific reproductive or developmental hazard data were found for this derivative or for taxifolin; peer‑reviewed work shows taxifolin is not a reproductive teratogen and can be protective in rodent models, so h/m remain 0. Exposure: no dermal absorption data for the pentacaprylate were located. Per instructions, when adult topical absorption evidence is lacking but the ingredient is not absolutely non‑absorbable, increase baby exposure by +1 due to higher baby surface‑area:body‑weight and immature barrier.
- VeriMom은 dihydroquercetin pentacaprylate을 어떻게 평가하나요?
- VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 dihydroquercetin pentacaprylate을 100/100 (알려진 위험 없음)로 평가합니다.
- 임신 중 dihydroquercetin pentacaprylate 대체 안전 성분은?
- 유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.
모든 성분표를 2초 만에 확인
VeriMom 무료 다운로드 — 어떤 제품이든 스캔해 임신 중 안전 점수를 즉시 확인하세요.
의료 면책 조항
이 정보는 교육 목적으로만 제공되며 의학적 조언을 구성하지 않습니다. 안전 점수는 공개적으로 이용 가능한 데이터를 기반으로 하며 모든 위험을 반영하지 않을 수 있습니다. 임신 중 또는 수유 중 제품을 사용하기 전에 항상 의료 전문가와 상담하십시오.